Outcome of board meeting is enclosed for ready reference

Kilitch Drugs (India) Ltd. KI 28" July, 2026 To, To, The Manager - Corporate Relationship The Manager - Corporate Compliance Dept. National Stock Exchange of India Ltd BSE Limited Exchange Plaza, Plot No.C-1, P. J. Towers, Dalal Street G Block, BKC, Bandra (E), Fort, Mumbai - 400 001 Mumbai 400 051 Scrip Code: BSE - 524500 Scrip Code: NSE - KILITCH Sub: Outcome of Board Meeting Dear Sir, Pursuant to Regulation 30 and Regulation 33 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby would like to inform you that the Board of Directors of the Company at its meeting held today ie. Tuesday, 28" July, 2026 have considered and approved the following; 1. Notice of 34 Annual General Meeting of the Company for the financial year ended 31 March, 2026 to be convened and held on Thursday, 27 August, 2026 at 9:00 am through video conferencing and other audio visual means only. 2. The Directors Report of the Company along with the Corporate Governance Report and all relevant annexures thereof for the financial year 2025-26. 3. Appointment of Mr. Deep Shukla, Practicing Company Secretary as Scrutinizer to conduct the entire voting process at the 34 AGM of the Company (including e-voting) and to submit the Report for declaration of the results thereof. 4. Pursuant to regulation 42 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Register of Members and Share Transfer Books of the Company shall remain closed from Thursday, 20" August, 2026 to Thursday, 27" August, 2026 (both days inclusive) pursuant to regulation 42 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 for the purpose of 34" AGM of the Company. 5. Re-appointment of M/s Arvind Kumar & Co. Cost Accountants (Firm Registration No. 000646) as Cost Auditors of the Company for financial year 2026-27. Brief Profile is enclosed as Annexure — A The Board Meeting commenced at 16:30 hours and concluded at 17:45 hours. Request you to kindly take note of the same and acknowledge the receipt. Thanking you, For Kilitch Drugs (India) Limited Mukund Mehta Managing Director Ny si 3991:3008 = WHO CERTIFIED a eR ono. Corporate office : 37/39, Ujagar Industrial Estate, W. T. Patil Marg, Deonar, Mumbai - 400 088. e Tel.: +91-22-6121 4100 « Fax : +91-22-6703 1658 Registered Office & Manufacturing unit : G-301/2, M.1.D.C., T.7.C. Industrial Area, Pawane Village, Navi Mumbai - 400 705. Maharashtra. « GIN: L24239MH1992PLC066718 « Tel.; +91-22-6299 6300 « Fax : +91-22-2768 0912 « E-mail : info@kilitch.com « Website : www.kilitch.com Kilitch Drugs (India) Ltd. Annexure — A Brief Profile of M/s Arvind Kumar & Co. Cost Accountants Firm Name Arvind Kumar & Co.,Cost Accountants Partner Name Mr. Arvind Kum ar Address D - 202, 2nd Fl oor, Vrushali Shilp, Chikuvadi, Link Road, Borivali (W), Mumbai - 400092 Membership No. 37904 Firm Registration number 000646 Email Id office.arvindk umarandco@ yahoo.com Accounts, Taxa tion (including international Taxation), ROC Area of experience Matters, Internal Audits, Cost Audits Disclosure of Relationships There is no relationship between directors and the cost between Directors in case auditor of appointment LEsERoY (L9ae)s, Vy Soy iwi. 139408051::22000038 WHO CE- RTIFIED Corporate office : 37/39, Ujagar Industrial Estate, W. T. Patil Marg, Deonar, Mumbai - 400 088. « Tel.: +91-22-6121 4100 « Fax : +91-22-6703 1658 Registered Office & Manufacturing unit : C-301/2, M.1.D.C., T.T.C. Industrial Area, Pawane Village, Navi Mumbai - 400 705. Maharashtra. e GIN: L24239MH1992PLC066718 « Tel.: +91-22-6299 6300 « Fax : +91-22-2768 0912 « E-mail : info@kilitch.com « Website : www.kilitch.com